Abeona Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 4.83, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Abeona Therapeutics Inc in Mar 31 2026 quarter, has decreased to 76 days, compared to 93 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 386 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2721, from overall ranking in the fourth quarter 2025 at 3390.

What is Receivable Turnover Ratio?
What is Abeona Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ABEO Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	314.9 %	306.48 %	0.19 %	-0.61 %	-27.55 %
Y / Y Revenue Change	669.01 %	581.04 %	40.62 %	19.82 %	55.4 %
Receivable Turnover Ratio (TTM)	4.83	3.93	3.34	3.04	2.89
ABEO's Total Ranking	# 2721	# 3390	# 3248	# 3326	# 3382
Accounts Receivable average collection period days	76	93	109	120	126
Seq. Receivable Change	-0.09 %	315.53 %	-0.86 %	0.8 %	-2.12 %
Seq. Revenue Change	44.6 %	316.69 %	17.17 %	8.93 %	28.05 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 118
Healthcare Sector	# 387
Overall Market	# 2721

Receivable Turnover Ratio Statistics
High	Average	Low
23.87	6.29	1.58
(Dec 31 2014)		(Jun 30 2024)

ABEO Company Profile • Back to ABEO Efficiency Comparisons • Compare ABEO Receivables Turnover Ratio to its Competitors

Financial Statements
Abeona Therapeutics Inc 's Accounts Receivable	$ 7 Millions	Visit ABEO's Balance sheet
Abeona Therapeutics Inc 's Sales TTM	$ 20 Millions	Visit ABEO's Income Statement
Sources of ABEO's Revenues		Visit ABEO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ABEO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ABEO's Growth Rates	ABEO's Roa	ABEO's Inventory Turnover Ratio	ABEO's Dividend Comparisons
ABEO's Profitability Ratios	ABEO's Roi	ABEO's Asset Turnover Ratio	ABEO's Dividend Growth
ABEO's Valuation Ratios	ABEO's Roe	ABEO's Financial Strength Ratios	ABEO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Atricure Inc	8.24	$ 549.625 Millions	$ 66.737 Millions
Aquestive Therapeutics Inc	8.16	$ 50.271 Millions	$ 6.158 Millions
Caredx Inc	8.16	$ 412.820 Millions	$ 50.605 Millions
Rockwell Medical inc	8.09	$ 67.550 Millions	$ 8.345 Millions
Concentra Group Holdings Parent Inc	8.08	$ 2,232.220 Millions	$ 276.283 Millions
Becton Dickinson And Company	8.02	$ 21,366.000 Millions	$ 2,662.500 Millions
Vycor Medical Inc	8.01	$ 1.886 Millions	$ 0.235 Millions
Sotera Health Company	8.01	$ 1,188.171 Millions	$ 148.349 Millions
Orthofix Medical Inc	7.99	$ 824.944 Millions	$ 103.310 Millions
Penumbra Inc	7.94	$ 1,454.283 Millions	$ 183.070 Millions
Alphatec Holdings Inc	7.93	$ 786.368 Millions	$ 99.110 Millions
Henry Schein Inc	7.92	$ 13,384.000 Millions	$ 1,689.500 Millions
Sight Sciences Inc	7.91	$ 78.550 Millions	$ 9.925 Millions
Aveanna Healthcare Holdings Inc	7.91	$ 2,521.890 Millions	$ 318.786 Millions
Trisalus Life Sciences Inc	7.91	$ 44.183 Millions	$ 5.586 Millions
Beta Bionics Inc	7.89	$ 110.003 Millions	$ 13.950 Millions
Acadia Pharmaceuticals Inc	7.88	$ 1,095.250 Millions	$ 138.935 Millions
Zymeworks Inc	7.87	$ 81.263 Millions	$ 10.324 Millions
Neuronetics Inc	7.82	$ 150.724 Millions	$ 19.272 Millions
Exelixis Inc	7.80	$ 2,375.491 Millions	$ 304.486 Millions
Idexx Laboratories Inc	7.79	$ 4,445.939 Millions	$ 570.842 Millions
Inspire Medical Systems inc	7.78	$ 915.060 Millions	$ 117.614 Millions
Myomo Inc	7.75	$ 41.180 Millions	$ 5.317 Millions
Pacs Group Inc	7.71	$ 5,432.276 Millions	$ 704.948 Millions
Acadia Healthcare Company Inc	7.70	$ 3,371.066 Millions	$ 437.934 Millions
Plus Therapeutics Inc	7.70	$ 5.182 Millions	$ 0.673 Millions
Quest Diagnostics Inc	7.69	$ 11,278.000 Millions	$ 1,467.500 Millions
Uniqure N v	7.68	$ 18.093 Millions	$ 2.356 Millions
Natera Inc	7.64	$ 2,500.927 Millions	$ 327.432 Millions
Cannapharmarx Inc	7.57	$ 1.654 Millions	$ 0.219 Millions

Date modified: 2026-06-22T20:36:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.